Ho Carole
SEC insider (Form 3/4/5 filer). CIK 0001724605. Director at Royalty Pharma plc (RPRX) and 3 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in NEW YORK, NY.
Companies Ho Carole has filed insider reports for
- Royalty Pharma plc (RPRX): Director
- ELI LILLY & Co (LLY): Officer, EVP & Pres, Lilly Neuroscience
- Denali Therapeutics Inc. (DNLI): Officer, Chief Medical Officer
- Beam Therapeutics Inc. (BEAM): Director
Ho Carole
CIK: 0001724605
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 5, 2026RPRX
Royalty Pharma plc
AwardDirect4.5K shares- - Aug 13, 2025DNLI
Denali Therapeutics Inc.
SaleDirect806 shares at avg. $14.64$12K - Aug 12, 2025DNLI
Denali Therapeutics Inc.
SaleDirect2.9K shares at avg. $13.58$40K - Aug 5, 2025DNLI
Denali Therapeutics Inc.
ExerciseDirect44.7K shares at avg. $0.68$30K - Jul 31, 2025RPRX
Royalty Pharma plc
AwardDirect2.8K shares- - Jul 31, 2025RPRX
Royalty Pharma plc
AwardDirect5.8K shares- - Jun 4, 2025BEAM
Beam Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
33.7K shares- - Jan 7, 2025DNLI
Denali Therapeutics Inc.
SaleDirect2.9K shares at avg. $20.81$60K - Jan 6, 2025DNLI
Denali Therapeutics Inc.
SaleDirect12.3K shares at avg. $20.22$248K - Jan 3, 2025DNLI
Denali Therapeutics Inc.
AwardDirect54.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  RPRX Royalty Pharma plc | Award | 4,545 | - | $0 | Direct |
| Aug 13, 2025 |  DNLI Denali Therapeutics Inc. | Sale | 806 | $14.64 | $11,800 | Direct |
| Aug 12, 2025 | DNLI Denali Therapeutics Inc. | Sale | 2,937 | $13.58 | $39,884 | Direct |
| Aug 5, 2025 | DNLI Denali Therapeutics Inc. | Exercise | 44,655 | $0.68 | $30,365 | Direct |
| Jul 31, 2025 | RPRX Royalty Pharma plc | Award | 2,752 | - | - | Direct |
| Jul 31, 2025 | RPRX Royalty Pharma plc | Award | 5,806 | - | - | Direct |
| Jun 4, 2025 |  BEAM Beam Therapeutics Inc. | Award Stock Option (Right to Buy) | 33,662 | - | - | Direct |
| Jan 7, 2025 | DNLI Denali Therapeutics Inc. | Sale | 2,907 | $20.81 | $60,495 | Direct |
| Jan 6, 2025 | DNLI Denali Therapeutics Inc. | Sale | 12,255 | $20.22 | $247,796 | Direct |
| Jan 3, 2025 | DNLI Denali Therapeutics Inc. | Award | 54,180 | - | $0 | Direct |
1-10 of 11 transactions